A study published in Aging Cell has identified immune resilience as a key driver of salutogenesis—the active process of ...

Antibodies are best known for their ability to latch onto and neutralize bacteria, viruses and other pathogens. But these immune proteins can do more than that: They also activate other components of ...

Host-pathogen interactions continue to challenge the fields of immunology and infectious disease research, as pathogens deploy a range of strategies to ...

Merck’s bifunctional immunotherapy M7824 just got its gold star—the FDA granted orphan drug designation for its use in ...

T-cell activation involves two phases, enabling a more precise immune response. This insight may boost cancer immunotherapy effectiveness. A research team led by Wolfgang Kastenmüller and Georg ...

A team of researchers from the University of Chicago, in collaboration with researchers from the University of Pittsburgh, ...

Tuberculosis (TB) is an infectious disease that kills more than a million people worldwide every year. The pathogen that ...